I would like to learn more about metabolic dysfunction-associated steatohepatitis (MASH). In particular, I am interested in better understanding the diagnostic tools that Clinical Pathologists and Endocrinologists utilize for diagnosing MASH and monitoring liver fibrosis stages. Additionally, I am curious about the gaps and limitations in the current diagnostic approaches for MASH patients and how public health experts and researchers in hepatology are working to address these challenges.

Learn More